Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$120,000.00

Tumour microenvironment & HPV ctDNA dynamics in HPV-related oropharyngeal cancer

FY 2024-25

Summary
The incidence of HPV-positive (HPV+) oropharyngeal cancer (OPC) is rising rapidly in high-income countries, driving the need for improved biomarkers for monitoring and prognostication. Plasma circulating-tumor DNA (ctDNA) has shown promise for cancer surveillance, reflecting cancer type, behavior, and gene expression. However, baseline HPV ctDNA abundance alone has proven insufficient for predicting relapse in HPV+ OPC patients. This study aims to explore the spatial characteristics of the TME and their influence on HPV ctDNA shedding in HPV+ OPC. We hypothesize that the variability in ctDNA shedding, kinetics, and minimal residual disease (MRD) detection is driven by the spatial organization of the TME. To test this hypothesis, we will utilize spatial transcriptomics with Visium HD to characterize cell populations in the TME of OPC tumors. We will analyze baseline tumor samples from a cohort of 263 HPV+ OPC patients treated with radiotherapy, coupled with peripheral blood plasma samples collected at baseline, mid-treatment, and multiple post-treatment timepoints. Spatial organization of cancer cells, stroma, and immune cells will be assessed, and the distribution of HPV-expressing cells will be examined for their association with ctDNA dynamics. The second aim is to evaluate the relationship between ctDNA shedding and TME features, such as immune-mediated cell death, and vascularization. We will correlate these spatial features with HPV ctDNA abundance and fragmentomic characteristics using targeted deep sequencing of the whole viral genome (HPV-seq). Lastly, we will develop a Bayesian generalized linear mixed model to longitudinally assess HPV ctDNA kinetics and MRD clearance, incorporating multiple factors, including disease burden and treatment impact. This research will leverage the largest prospective cohort of HPV+ OPC patients to uncover drivers of ctDNA shedding variability, potentially refining risk stratification and improving patient management.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
518381
Name
Penny Lucas
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Tumour microenvironment & HPV ctDNA dynamics in HPV-related oropharyngeal cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Cancer Management; Cancer Treatment Risk Stratification; Cell-Free Dna/ Circulating-Tumour Dna; Hpv; Liquid Biopsy; Next-Generation Sequencing; Oropharyngeal Cancer; Targeted Sequencing
Abstract
The incidence of HPV-positive (HPV+) oropharyngeal cancer (OPC) is rising rapidly in high-income countries, driving the need for improved biomarkers for monitoring and prognostication. Plasma circulating-tumor DNA (ctDNA) has shown promise for cancer surveillance, reflecting cancer type, behavior, and gene expression. However, baseline HPV ctDNA abundance alone has proven insufficient for predicting relapse in HPV+ OPC patients. This study aims to explore the spatial characteristics of the TME and their influence on HPV ctDNA shedding in HPV+ OPC. We hypothesize that the variability in ctDNA shedding, kinetics, and minimal residual disease (MRD) detection is driven by the spatial organization of the TME. To test this hypothesis, we will utilize spatial transcriptomics with Visium HD to characterize cell populations in the TME of OPC tumors. We will analyze baseline tumor samples from a cohort of 263 HPV+ OPC patients treated with radiotherapy, coupled with peripheral blood plasma samples collected at baseline, mid-treatment, and multiple post-treatment timepoints. Spatial organization of cancer cells, stroma, and immune cells will be assessed, and the distribution of HPV-expressing cells will be examined for their association with ctDNA dynamics. The second aim is to evaluate the relationship between ctDNA shedding and TME features, such as immune-mediated cell death, and vascularization. We will correlate these spatial features with HPV ctDNA abundance and fragmentomic characteristics using targeted deep sequencing of the whole viral genome (HPV-seq). Lastly, we will develop a Bayesian generalized linear mixed model to longitudinally assess HPV ctDNA kinetics and MRD clearance, incorporating multiple factors, including disease burden and treatment impact. This research will leverage the largest prospective cohort of HPV+ OPC patients to uncover drivers of ctDNA shedding variability, potentially refining risk stratification and improving patient management.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Penny, Lucas
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~